The largest database of trusted experimental protocols

Insulatard

Manufactured by Novo Nordisk
Sourced in Denmark

Insulatard is a long-acting insulin product used for the treatment of diabetes. It is a sterile, white, aqueous suspension of crystalline insulin and insulin zinc suspension designed for subcutaneous administration.

Automatically generated - may contain errors

5 protocols using insulatard

1

Glucose and Insulin Tolerance Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
At 8 weeks, animals were fasted overnight, and an oral glucose load was administered at 2 g/kg body weight. Blood glucose levels were measured from the tail vein before and at 15, 30, 60, 90, and 120 min after glucose administration. Glucose tolerance was evaluated by calculating the areas under the curve (AUCs).
The insulin tolerance test (ITT) was performed by injecting 1 U/kg human insulin (Insulatard; Novo Nordisk, Bagsvaerd, Denmark) after a 6-h fast 3 days before the end of the experiment. Blood glucose levels were measured at 0, 30, 60, 90, and 120 min after insulin injection. Glucose tolerance was evaluated by calculating the AUCs.
+ Open protocol
+ Expand
2

Glucose and Insulin Tolerance Tests

Check if the same lab product or an alternative is used in the 5 most similar protocols
Glucose tolerance test (GTT) and insulin tolerance test (ITT) were performed in 16 h- or 6 h-fasted mice. Animals received an intraperitoneal injection of glucose (1 g/kg b.w.) or insulin (0.5 U/kg b.w., Insulatard, Novo Nordisk). Blood glucose was monitored for 120 min using a glucometer (Accu-Check, Roche) on blood samples collected from the tail vein. Insulin and glucagon were quantified using Mouse Insulin or Glucagon Elisa kits (Mercodia).
+ Open protocol
+ Expand
3

Streptozotocin-Induced Diabetic Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
Streptozotocin (STZ) was purchased from Sigma-Aldrich, USA. Fructose was obtained from El-Nasr Pharmaceutical chemicals Company, Egypt and the long-acting insulin (Insulatard) from Novo Nordisk A/S, Denmark. Escitalopram oxalate (Cipralex) was purchased from H. Lundbeck A/S, Denmark. Escitalopram was freshly prepared in saline immediately before use and administered orally. All other chemicals and reagents, unless specified, were obtained from Sigma-Aldrich, United States.
+ Open protocol
+ Expand
4

Glucose and Insulin Tolerance Tests

Check if the same lab product or an alternative is used in the 5 most similar protocols
Glucose tolerance test (GTT) and insulin tolerance test (ITT) were carried out 2 and 3 weeks after the surgery, respectively. Animals were fasted for 16 (GTT) or 6 hrs (ITT) and then received an intraperitoneal injection of glucose (1 g/kg) or insulin (0.75 IU/kg for obese mice and 0.5 IU/kg for lean mice, Insulatard, Novo Nordisk). Blood glucose was monitored for 120 (GTT) or 90 min (ITT) using a glucometer (Accu-Check, Roche) From samples collected from the tip of the tail vein. Insulinemia was quantified using an ELISA kit (Mercodia).
+ Open protocol
+ Expand
5

Insulin Dosing for Stable Hyperglycemia in Rabbits

Check if the same lab product or an alternative is used in the 5 most similar protocols
Once stable hyperglycemia (constant hyperglycemic state without relapse) was confirmed, BGLs in the rabbits were measured twice a day using the same blood glucometer. If the BGL was higher than 350 mg/dL, long-acting insulin (Insulatard®, Novo Nordisk A/S, Denmark) was administered subcutaneously once or twice daily with an insulin pen. The dose was adjusted according to the BGL for the individual rabbit based on the following protocol previously reported by Wang et al. [13 (link)]:

BGL = 350–450 mg/dL received 1 U/kg

BGL = 450–550 mg/dL received 2 U/kg

BGL = 550–600 mg/dL received 3 U/kg

BGL >600 mg/dL received 4 U/kg

+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!